Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
The decision to terminate the trial was based on a lack of study drug supply. The decision was not based on any safety concerns. The termination letter was sent on 11March2011.
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Be able to read, speak and understand English
Have chronic moderate to severe pain for at least 3 months
Require around the clock opioid medication for the relief of pain
Have been taking a daily opioid for at least 30 days prior to starting the study
Be able to be safely switched to a different pain medication
Be practicing acceptable birth control methods for female patients of childbearing potential
Be willing to participate in the study and able to comply with study procedures
You may not be if
Be currently diagnosed with or participating in and/or seeking treatment for opioid and/or alcohol abuse
Be allergic or intolerant to morphine, morphine salts, naltrexone or other opioids
Be currently taking tramadol and/or extended release morphine products
Have respiratory depression
Have acute or severe bronchial asthma or severe chronic obstructive pulmonary disease
Have migraines as your main source of pain
Have any form of bowel obstruction
Be pregnant or breast feeding
Have had 2 or more surgeries for low back pain
Be planning a major surgery during the study
Be staying in a hospital or nursing home
Be planning to have steroid injections for your chronic pain during the study
Have a life expectancy of less than 2 months
Clareo Health | Conversion to Embeda With Rescue Trial
